StockNews.AI
GSRT
StockNews.AI
3 hrs

Terra Innovatum and GSR III Acquisition Corp. Remind Shareholders to Vote and Approve the Business Combination Prior to the October 7 Extraordinary General Meeting of Shareholders

1. GSRT urges shareholders to vote for the business combination. 2. Extraordinary General Meeting scheduled for October 7, 2025. 3. Post-merger, GSRT operates as Terra Innovatum under Ticker 'NKLR'. 4. Terra Innovatum's SOLO™ reactor targets commercialization by 2028. 5. SOLO™ offers scalable, safe, and affordable nuclear power solutions.

17m saved
Insight
Article

FAQ

Why Bullish?

The upcoming merger with a promising clean energy company could enhance GSRT's market position. Historical performance of similar SPAC mergers show positive market reactions.

How important is it?

The shareholders' vote on the merger is critical; it directly affects GSRT's future. The merger aligns with renewable energy trends, which have growing investor interest.

Why Long Term?

If the merger succeeds, it may significantly boost GSRT's valuation over the next few years. The commitment to 2028 commercialization signifies further growth expectations.

Related Companies

NKLR
GSRT shareholders are encouraged to use their voice and vote FOR the business combination and other proposals ahead of the deadline on October 6, 2025, at 11:59 p.m. ET Shareholders as of September 15, 2025, should vote their shares even if they no longer own them NEW YORK and AUSTIN, Texas, Sept. 30, 2025 (GLOBE NEWSWIRE) -- Terra Innovatum Srl ("Terra Innovatum" or the “Company”), a developer of micro-modular nuclear reactors, and GSR III Acquisition Corp. ("GSRT") (Nasdaq: GSRT), a publicly traded special purpose acquisition company, remind GSRT shareholders to vote "FOR" their proposed business combination and all other proposals detailed in the definitive proxy statement/prospectus (the "Proxy Statement"). Shareholder Meeting Details GSR III Acquisition Corp. will hold its extraordinary general meeting of shareholders (the “Extraordinary General Meeting”) via live webcast at https://www.cstproxy.com/gsriii/2025 on October 7, 2025, at 11:00 a.m., Eastern Time, to approve the business combination with Terra Innovatum and related matters. GSRT shareholders of record as of September 15, 2025, are entitled to vote at the Extraordinary General Meeting and should have received by mail a Proxy Statement with instructions on how to vote their shares. GSRT shareholders who need assistance voting, have questions regarding the Extraordinary General Meeting, or would like to request documents may contact GSRT’s proxy solicitor Sodali & Co. at (800) 662-5200 (banks and brokers can call (203) 658-9400) or by emailing GSRT.info@investor.sodali.com. If the necessary proposals are approved, Terra Innovatum and GSRT anticipate that the business combination will close shortly after the Extraordinary General Meeting. The post-combination company will operate under the name Terra Innovatum and its common shares are expected to trade on Nasdaq under the ticker symbol “NKLR,” subject to the satisfaction of all other listing conditions. Terra Innovatum is Advancing a Differentiated Nuclear Solution with a 2028 Commercialization Target Terra Innovatum is redefining the future of clean, reliable power with its scalable energy solution, the SOLO™ micro-modular nuclear reactor, and has made tremendous progress towards its 2028 commercialization target by securing a deployment site and component and fuel manufacturing partners. The Company’s reactor design, licensing path, and deployment strategy are differentiated from traditional large-scale reactors as well as small modular reactors: Proliferation-Resistant LEU Fuel: SOLO uses uranium enriched to less than 5%, eliminating proliferation concerns while enabling safe, global deployment without near-term dependence on fuels under development like HALEU. SOLO will adopt HALEU when it becomes commercially available at scale.Inherent Safety by Design: Physics-based safety ensures no risk of meltdown or hydrogen explosions by design. Low thermal output and robust shielding allow deployment without the need of an emergency planning zone.Factory-Assembled & Modular: Designed to be entirely manufactured and integrated in controlled factory settings, then transported to site. Scalable from single units to gigawatt-class output, supporting applications from electricity and process heat to cogeneration and medical radioisotopes production.Streamlined Licensing Path: Built exclusively with proven, off-the-shelf fuels and components, avoiding experimental materials and laboratory-scale testing. This de-risks regulatory review and accelerates commercialization.Compact, Small footprint and Site Agnostic: At just 35 ft × 35 ft and requiring no emergency planning zone, SOLO is uniquely deployable across industrial hubs, remote regions or near urban areas.Flexible Grid Integration: SOLO can operate off-grid for military, mining, or data center applications, or connect to the grid to enhance resilience and stability through reliable baseload power.Commercially Ready with Predictable Costs: Global supply chain and standardized manufacturing in place, enabling predictable costs, scalability, and rapid deployment at commercial scale. ABOUT GSR III GSR III Acquisition Corp. is a blank check company incorporated in the Cayman Islands with the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more operating businesses. GSRT is led by a highly experienced sponsor team with a strong track record in SPAC transactions, having previously sponsored two SPACs and advised on over 20 successful SPAC completions. The company's management team includes Co-Chief Executive Officers Mr. Gus Garcia and Mr. Lewis Silberman, President and Chief Financial Officer Mr. Anantha Ramamurti, and Chief Business Development Officer Mr. Yuya Orime. ABOUT TERRA INNOVATUM & SOLO™ Terra Innovatum's mission is to make nuclear power accessible. We deliver simple and safe micro-reactor solutions that are scalable, affordable and deployable anywhere 1 MWe at a time. Terra Innovatum is a pioneering force in the energy sector, dedicated to delivering innovative and sustainable power solutions. Terra Innovatum plans to leverage cutting-edge nuclear technology through the SOLO™ Micro-Modular Reactor (SMR™) to provide efficient, safe, and environmentally conscious energy. With a mission to address global energy shortages, Terra Innovatum combines extensive expertise in nuclear industry design, manufacturing, and installation licensing to offer disruptive energy solutions. Committed to propelling technological advancements, Terra Innovatum and SOLO™ are dedicated to fostering prosperity and sustainability for humankind. It is anticipated that SOLO™ will be available globally within the next three years. Conceptualized in 2018 and engineered over six years by experts in nuclear safety, licensing, innovation, and R&D, SOLO™ addresses pressing global energy demands with a market-ready solution. Built from readily available commercial off-the-shelf components, the proven licensing path for SOLO™ enables rapid deployment and minimizes supply chain risks, ensuring final cost predictability. Designed to adapt with evolving fuel options, SOLO™ supports both LEU+ and HALEU, offering a platform ready to transition to future fuel supplies. SOLO™ will offer a wide range of versatile applications, providing CO2-free, behind-the-meter, and off-grid power solutions for data centers, mini-grids serving remote towns and villages, and large-scale industrial operations in hard-to-abate sectors like cement production, oil and gas, steel manufacturing, and mining. It also has the ability to supply heat for industrial applications and other specialized processes, including water treatment, desalination and co-generation. Thanks to its modular design, SOLO™ can easily scale to deliver up to 1GW or more of CO2-free power with a minimal footprint, making it an ideal solution for rapidly replacing fossil fuel-based thermal plants. Beyond electricity and heat generation, SOLO™ can also contribute to critical applications in the medical sector by producing radioisotopes essential for oncology research and cancer treatment. To learn more, visit: www.terrainnovatum.com. CONTACTS Giordano MorichiPartner, Chief Business Development Officer & Investor RelationsTerra Innovatum SrlE: g.morichi@terrainnovatum.comW: www.terrainnovatum.com Anantha RamamurtiPresident, Chief Financial Officer GSR III Acquisition CorpE: anantha@gsrspac.comP: (949) 468-7434 Nicholas Hresko-StaabVice President Investor & Media RelationsAlliance Advisors IRE: TerraIR@allianceadvisors.com IMPORTANT INFORMATION FOR SHAREHOLDERS This communication does not constitute an offer to sell or the solicitation of an offer to buy any securities or constitute a solicitation of any vote or approval. PARTICIPANTS IN THE SOLICITATION Each of the Registrant Parties, and their respective directors and executive officers, may be considered participants in the solicitation of proxies with respect to the potential transaction described in this communication under the rules of the SEC. Information about the directors and executive officers of GSRT is set forth in GSRT’s filings with the SEC. Information regarding other persons who may, under the rules of the SEC, be deemed participants in the solicitation of the shareholders in connection with the potential transaction and a description of their direct and indirect interests will be set forth in the Registration Statement (and will be included in the proxy statement/prospectus) and other relevant documents when they are filed with the SEC. These documents can be obtained free of charge from the sources indicated above. FORWARD LOOKING STATEMENTS The statements contained in this press release that are not purely historical are forward-looking statements. These forward-looking statements include, but are not limited to, statements regarding our expectations, hopes, beliefs, intentions or strategies regarding the future. In addition, any statements that refer to projections, forecasts or other characterizations of future events or circumstances, including any underlying assumptions, are forward-looking statements. The words “anticipate,” “believe,” “continue,” “could,” “estimate,” “expect,” “intends,” “may,” “might,” “plan,” “possible,” “potential,” “predict,” “project,” “should,” “would” and similar expressions may identify forward-looking statements, but the absence of these words does not mean that a statement is not forward-looking. The forward-looking statements contained in this press release are based on our current expectations and beliefs concerning future developments and their potential effects on GSRT and the other Registrant Parties. There can be no assurance that future developments affecting GSRT and the other Registrant Parties will be those that we have anticipated. These forward-looking statements speak only as of the date this press release is delivered and involve a number of risks, uncertainties (some of which are beyond our control) or other assumptions that may cause actual results or performance to be materially different from those expressed or implied by these forward-looking statements. Should one or more of these risks or uncertainties materialize, or should any of our assumptions prove incorrect, actual results may vary in material respects from those projected in these forward-looking statements. Factors that may cause actual results to differ materially from current expectations include, but are not limited to: (1) the occurrence of any event, change or other circumstances that could give rise to the termination of the definitive agreements with respect to the Business Combination; (2) the outcome of any legal proceedings that may be instituted against GSRT, any of the Registrant Parties, the combined company or others following the announcement of the Business Combination and any definitive agreements with respect thereto; (3) the inability to complete the Business Combination due to the failure to obtain approval of the shareholders of GSRT or the SEC’s declaration of the effectiveness of the Registration Statement (which will include the proxy statement/prospectus contained therein) to be filed by the Registrant Parties or to satisfy other conditions to closing; (4) changes to the proposed structure of the Business Combination that may be required or appropriate as a result of applicable laws or regulations or as a condition to obtaining regulatory approval of the Business Combination; (5) the ability of Pubco to meet stock exchange listing standards following the consummation of the Business Combination; (6) the risk that the Business Combination disrupts current plans and operations of Terra Innovatum as a result of the announcement and consummation of the Business Combination; (7) the ability to recognize the anticipated benefits of the Business Combination, which may be affected by, among other things, competition, the ability of the combined company to grow and manage growth profitably, maintain relationships with customers and suppliers and retain its management and key employees; (8) costs related to the Business Combination, including the reorganization described in the business combination agreement; (9) changes in applicable laws or regulations; (10) the possibility that the Registrant Parties or the combined company may be adversely affected by other economic, business, and/or competitive factors; (11) the amount of redemption requests made by GSRT shareholders and (12) other risk factors described herein as well as the risk factors and uncertainties described in the Form S-4 and GSRT’s other filings with the SEC, as well as any further risks and uncertainties to be contained in the proxy statement/prospectus filed after the date hereof. In addition, there may be additional risks that neither GSRT nor any of the other Registrant Parties presently know, or that GSRT or the other Registrant Parties currently believe are immaterial, that could also cause actual results to differ from those contained in the forward-looking statements. Nothing in this communication should be regarded as a representation by any person that the forward- looking statements set forth herein will be achieved or that any of the contemplated results of such forward-looking statements will be achieved. You should not place undue reliance on forward-looking statements, which speak only as of the date they are made. None of GSRT, the other Registrant Parties, or any of their respective affiliates, officers, employees or agents, makes any representation or warranty, either express or implied, in relation to the fairness, reasonableness, adequacy, accuracy, completeness or reliability of the information, statements or opinions, whichever their source, contained in this press release or any oral information provided in connection herewith, or any data it generates and accept no responsibility, obligation or liability (whether direct or indirect, in contract, tort or otherwise) in relation to any of such information. GSRT, the other Registrant Parties and their respective affiliates, officers, employees and agents further expressly disclaim any and all liability relating to or resulting from the use of this press release and any errors therein or omissions therefrom. Further, the information contained herein is preliminary, is provided for discussion purposes only, is only a summary of key information, is not complete and is subject to change without notice. In addition, the information contained in this press release is provided as of the date hereof and may change, and neither GSRT nor the other Registrant Parties undertakes any obligation to update or revise any forward- looking statements, whether as a result of new information, inaccuracies, future events or otherwise, except as may be required under applicable securities laws.

Related News